Skip to main content
. 2011 Jul 15;52(8):5174–5182. doi: 10.1167/iovs.11-7272

Figure 4.

Figure 4.

The stability of preexisting Cx43 is altered after MMC treatment. Cells were treated with prewarmed media containing 10 μg/mL CHX with or without 5 μM MMC for indicated times in minutes. Blot shows total Cx43 using a C-terminal–specific antibody. Blots were stripped and reprobed for α-tubulin as a loading control. Quantification below is ratio of Cx43/α-tubulin normalized to the zero time (0) for “CHX” or “CHX + MMC.” Asterisks indicate statistically significant differences between “CHX” and “CHX + MMC” (2-way ANOVA, P < 0.01; Bonferroni multiple comparisons, P < 0.05). Results are representative of three independent experiments and mean fold change ± SEM is shown in the graph.